Citation | Barlind, JG; Bauer, UA; Birch, AM; Birtles, S; Buckett, LK; Butlin, RJ; Davies, RD; Eriksson, JW; Hammond, CD; Hovland, R; Johannesson, P; Johansson, MJ; Kemmitt, PD; Lindmark, BT; Morentin Gutierrez, P; Noeske, TA; Nordin, A; O'Donnell, CJ; Petersson, AU; Redzic, A; Turnbull, AV; Vinblad, J Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687). J Med Chem55:10610-29 (2012) [PubMed] Article |
---|
SMILES | NC(=O)c1cncc(n1)-c1ccc(cc1)[C@H]1CC[C@H](CCO)CC1 |r,wU:15.16,wD:18.20,(57.84,-21.32,;59.18,-20.56,;59.18,-19.02,;60.51,-21.33,;60.51,-22.87,;61.85,-23.64,;63.18,-22.87,;63.18,-21.33,;61.84,-20.56,;64.51,-20.56,;65.84,-21.34,;67.18,-20.56,;67.17,-19.01,;65.84,-18.25,;64.51,-19.02,;68.51,-18.24,;68.5,-16.71,;69.83,-15.93,;71.17,-16.7,;72.5,-15.93,;73.84,-16.7,;75.17,-15.93,;71.17,-18.24,;69.84,-19.01,)| |